COVID-19: Toxicities of Potential Therapies

May 13, 2020 • 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 26, 2019 • 00:27:15
Episode Cover

Updates in Post-Arrest Care

Over 500,000 patients suffer sudden cardiac arrest each year in the United States.  Though survival rates are improving, there remains significant variation in outcomes...

Listen

Episode 0

June 03, 2019 • 00:20:43
Episode Cover

Early Post-Cardiac Arrest Catheterization - The COACT Trial

A critical component to post-arrest care for the patient with ROSC following out-of-hospital cardiac arrest is early coronary angiography. Current guidelines recommend immediate cardiac...

Listen

Episode 0

July 18, 2022 • 00:27:41
Episode Cover

TAVR Complications You Need to Know!

Transcatheter aortic valve replacement is now more common than open surgical replacement and may be associated with lower mortality.  Given the significant increase in...

Listen